Related Experiment Video
Updated: Jun 15, 2025
Recapitulation of an Ion Channel IV Curve Using Frequency Components
Published on: February 8, 2011
Computational insights into the mechanisms underlying structural destabilization and recovery in
Sara AlRawashdeh1, Farag E S Mosa1, Khaled H Barakat1
1Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.
Insights
Mutations causing Long QT Syndrome (LQTS) disrupt hERG channel structure, leading to ER retention. A drug, E-4031, rescues these channels by preventing structural changes, offering a potential cellular therapy for LQTS patients.
Area of Science:
- Cardiovascular science
- Molecular biology
- Biophysics
Background:
- Cardiovascular diseases and cardiac arrhythmias are leading causes of death globally.
- Hereditary Long QT Syndrome (LQTS) increases sudden cardiac death risk due to prolonged QT intervals.
- LQT2, a common LQTS type, stems from hERG gene mutations affecting potassium channels, often causing intracellular retention.
Purpose of the Study:
- Investigate the structural impact of hERG mutations in LQT2.
- Elucidate the mechanism of endoplasmic reticulum (ER) retention and degradation of mutant hERG channels.
- Determine how E-4031 rescues trafficking-deficient hERG mutants.
Main Methods:
- Utilized accelerated molecular dynamics simulations.
- Analyzed structural changes in the hERG channel, including pore conformation and intracellular domains.
- Assessed the effect of E-4031 on mutant hERG channel structure and trafficking.
Main Results:
- hERG mutations induce structural alterations, narrowing the central pore and modifying intracellular domains.
- These structural changes expose signals promoting ER retention and degradation of mutant channels.
- The drug E-4031 inhibits these detrimental structural changes, suggesting a rescue mechanism.
Conclusions:
- Mutant hERG channels exhibit specific structural defects leading to ER retention and degradation.
- E-4031 demonstrates potential to rescue these channels by stabilizing their structure.
- Understanding these structural defects can guide the development of mechanism-based therapies for LQTS.
Abstract:
Cardiovascular diseases are a major global health concern, responsible for a significant number of deaths each year, often linked to cardiac arrhythmias resulting from dysfunction in ion channels. Hereditary Long QT Syndrome (LQTS) is a condition characterized by a prolonged QT interval on ECG, increasing the risk of sudden cardiac death. The most common type of LQTS, LQT2, is caused by mutations in the hERG gene, affecting a potassium ion channel. The majority of these mutations disrupt the channel's trafficking to the cell membrane, leading to intracellular retention. Specific high-affinity hERG blockers (e.g., E-4031) can rescue this mutant phenotype, but the exact mechanism is unknown. This study used accelerated molecular dynamics simulations to investigate how these mutations affect the hERG channel's structure, folding, endoplasmic reticulum (ER) retention, and trafficking. We reveal that these mutations induce structural changes in the channel, narrowing its central pore and altering the conformation of the intracellular domains. These changes expose internalization signals that contribute to ER retention and degradation of the mutant hERG channels. Moreover, the study found that the trafficking rescue drug E-4031 can inhibit these structural changes, potentially rescuing the mutant channels. This research offers valuable insights into the structural issues responsible for the degradation of rescuable transmembrane trafficking mutants. Understanding the defective trafficking structure of the hERG channel could help identify binding sites for small molecules capable of restoring proper folding and facilitating channel trafficking. This knowledge has the potential to lead to mechanism-based therapies that address the condition at the cellular level, which may prove more effective than treating clinical symptoms, ultimately offering hope for individuals with hereditary Long QT Syndrome.
